Table 2. Antimicrobial susceptibility pattern of MDR-AB.
Antibiotics | Susceptible, n (%) | Intermediate, n (%) | Resistant, n (%) | Total |
Ceftazidime | 34 (41) | 0 | 49 (59) | 83 |
Doxycycline | 42 (51) | 1 (1) | 40 (48) | 83 |
Levofloxacin | 51 (61) | 3 (4) | 29 (35) | 83 |
Meropenem | 32 (38) | 1 (1) | 51 (61) | 83 |
Imipenem | 30 (36) | 2 (3) | 51 (61) | 83 |
Ceftriaxone | 21 (25) | 1 (1) | (74) | 83 |
Cefotaxime | 25 (30) | 1 (1) | 57 (69) | 83 |
Piperacillin tazobactam | 46 (56) | 1 (1) | 36 (43) | 83 |
Cotrimoxazole | 36 (43) | 1 (1) | 46 (56) | 83 |
Cefepime | 31 (37) | 1 (1) | 51 (62) | 83 |
Gentamicin | 42 (51) | 2 (2) | 39 (47) | 83 |
Tobramycin | 46 (55) | 1 (1) | 36 (44) | 83 |
Amikacin | 38 (46) | 2 (2) | 43 (52) | 83 |
Ciprofloxacin | 44 (53) | 1 (1) | 38 (46) | 83 |